{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T05:42:38Z","timestamp":1789882958126,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T00:00:00Z","timestamp":1537228800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Funda\u00e7\u00e3o Arauc\u00e1ria - Programa Pesquisa para o SUS","award":["34935.406.36850.19112012"],"award-info":[{"award-number":["34935.406.36850.19112012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12929-018-0472-y","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T12:06:29Z","timestamp":1537272389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Genetic variant in CXCL12 gene raises susceptibility to HPV infection and squamous intraepithelial lesions development: a case-control study"],"prefix":"10.1186","volume":"25","author":[{"given":"N\u00e1dia Calvo Martins","family":"Okuyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Cezar-dos-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9rica Rom\u00e3o","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kleber Paiva","family":"Trugilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme Cesar Martelossi","family":"Cebinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle Mota","family":"Sena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula Lombardi","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano Martin Felis","family":"Aranome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Fernando Lasaro","family":"Mangieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo Sanches","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Angelica Ehara","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9666-6963","authenticated-orcid":false,"given":"Karen Braj\u00e3o","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,18]]},"reference":[{"key":"472_CR1","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1086\/587698","volume":"197","author":"H Trottier","year":"2008","unstructured":"Trottier H, Mamud S, Prado JCM, Sobrinho JS, Costa MC, Rohan TE, et al. Type-scpecific duration of human papillomavirus infections: implications for human papillomavirus screening and vaccination. J Infec. Disease. 2008;197:1436\u201347.","journal-title":"J Infec. Disease"},{"issue":"1","key":"472_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.bjid.2015.10.008","volume":"20","author":"J Coser","year":"2016","unstructured":"Coser J, Boeira TR, Wolf JM, Cerbado K, Simon D, Lunge VR. Cervical human papillomavirus infection and persistence: a clinic-based study in the countryside from South Brazil. Braz J Infect Dis. 2016;20(1):61\u20138.","journal-title":"Braz J Infect Dis"},{"issue":"12","key":"472_CR3","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.1172\/JCI57149","volume":"121","author":"PE Gravitt","year":"2011","unstructured":"Gravitt PE. The known unknwons of HPV natural history. J Clin Investig. 2011;121(12):4593\u20139.","journal-title":"J Clin Investig"},{"key":"472_CR4","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.virol.2008.11.046","volume":"384","author":"H Zur hausen","year":"2009","unstructured":"Zur hausen H. Papillomaviruses in the causation of human cancers - a brief historical account. Virology. 2009;384:260\u201326.","journal-title":"Virology"},{"key":"472_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc2050","volume":"7","author":"CBJ Woodman","year":"2007","unstructured":"Woodman CBJ, Collins SI, Young LS. The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer. 2007;7:11\u201322.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"472_CR6","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.3390\/v5112624","volume":"5","author":"A Amador-molina","year":"2013","unstructured":"Amador-molina A, Hern\u00e1ndez-Valencia JF, Lamoyi E, Contreras-Paredes A, Lizano M. Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response. Viruses. 2013;5(11):2624\u201342.","journal-title":"Viruses"},{"key":"472_CR7","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00280-008-0881-9","volume":"63","author":"F Mbeunkui","year":"2010","unstructured":"Mbeunkui F, Johann DJ Jr. Cancer and the tumor microenvironment: a review of an essential relationship. Cancer chemoter pharmacol. 2010;63:571\u201382.","journal-title":"Cancer chemoter pharmacol"},{"key":"472_CR8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.canlet.2008.04.050","volume":"267","author":"J Vandercappellen","year":"2008","unstructured":"Vandercappellen J, Damme JD, Struyf S. The role of CXC chemokines and their receptors in cancer. Cancer Lett. 2008;267:226\u201344.","journal-title":"Cancer Lett"},{"issue":"15","key":"472_CR9","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.4049\/jimmunol.1501063","volume":"197","author":"W Zhou","year":"2016","unstructured":"Zhou W, Zhang J, Goleniewska K, Dulek DE, Toki S, Newcomb DC, et al. Prostaglandin I2 supresses proinflammatory chemokine expression, CD4 T cell activation, and stat6-independent allergic lung inflammation. J Immunol. 2016;197(15):1577\u201386.","journal-title":"J Immunol"},{"key":"472_CR10","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1006\/geno.1995.1180","volume":"28","author":"M Shirozu","year":"1995","unstructured":"Shirozu M, Nakano T, Inazawa J, Tashiro K, Tada H, Shinohara T, et al. Struture and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics. 1995;28:495\u2013500.","journal-title":"Genomics"},{"key":"472_CR11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1126\/science.279.5349.389","volume":"279","author":"C Winkler","year":"1998","unstructured":"Winkler C, Modi W, Smith MW, Nelson GW, Wu X, Carrington M, et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. Alive study, hemophilia growth and development study (hgds), multicenter AIDS cohort study (macs), multicenter hemophilia cohort study (MHCS), san Francisco City cohort (SFCC). Science. 1998;279:389\u201393.","journal-title":"Science"},{"issue":"2","key":"472_CR12","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.cyto.2011.04.017","volume":"55","author":"KB De Oliveira","year":"2011","unstructured":"De Oliveira KB, Guembarovski RL, Oda JMM, Mantovani MS, Carrera CM, Reiche EMV, et al. CXCL12 rs1801157 polymorphism and expression in peripheral blood from breast cancer patients. Cytokine. 2011;55(2):260\u20135.","journal-title":"Cytokine"},{"issue":"6","key":"472_CR13","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1744-313X.2009.00877.x","volume":"3","author":"SN Maley","year":"2009","unstructured":"Maley SN, Schwatz SM, Johnson LG, Malkki M, Du Q, Daling JR, et al. Genetic variation in CXCL12 and risk of cervical carcinoma: a population-based case-control study. International Journal Immunogenet. 2009;3(6):367\u201375.","journal-title":"International Journal Immunogenet"},{"key":"472_CR14","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.3892\/mmr.2015.3315","volume":"11","author":"A Roszak","year":"2015","unstructured":"Roszak A, Misztal M, Sowinska A, Jagodzinski PP. Stromal cell-derived factor-1 G801A polymorphism and the risk factors for cervical cancer. Mol Med Rep. 2015;11:4633\u20138.","journal-title":"Mol Med Rep"},{"issue":"4","key":"472_CR15","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1001\/jama.1991.03460040048027","volume":"265","author":"HM Bauer","year":"1992","unstructured":"Bauer HM, Ting Y, Greer CE, Chambers JC, Tashiro CJ, Chimera J, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. Jama. 1992;265(4):472\u20137.","journal-title":"Jama"},{"key":"472_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/146079","volume":"2013","author":"Amanda Vansan Marangon","year":"2013","unstructured":"Marangon AV, Guelsin GAS, Visentainer JEL, Borelli SD, Watanabe MAE, et al. The association of the immune response genes to human papillomavirus-related cervical disease in a brazilian population. Biomed Res Int. 2013:1\u201311.","journal-title":"BioMed Research International"},{"issue":"7","key":"472_CR17","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","volume":"7","author":"S Sanjos\u00e9","year":"2007","unstructured":"Sanjos\u00e9 S, Castellsagu\u00e9 X, Clifford G, Bruni L, Mu\u00f1oz N, Boshi FX. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007;7(7):453\u20139.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"472_CR18","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1097\/AOG.0b013e3182571f47","volume":"119","author":"lY Hwang","year":"2012","unstructured":"Hwang lY, Lieberman JA, Ma Y, Farhat S, Moscicki AB. Cervical ectopy and the acquisition of human papillomavirus in adolescents and young women. Obstet Gynecol. 2012;119(6):1164\u201370.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"472_CR19","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3109\/10408449009089870","volume":"20","author":"JD Johnson","year":"1990","unstructured":"Johnson JD, Houchens DP, Kluwe WM, Craign DK, Fisher GL. Effects of mainstream and environmental tobacco smoke on the immune system in animals and humans\u00a0: a review. Critic rev toxicol. 1990;20(5):369\u201395.","journal-title":"Critic rev toxicol"},{"issue":"12","key":"472_CR20","doi-asserted-by":"publisher","first-page":"6084","DOI":"10.1128\/JVI.00103-08","volume":"82","author":"PE Castle","year":"2008","unstructured":"Castle PE. How does tobacco smoke contribute to cervical carcinogenesis? J Virol. 2008;82(12):6084\u20136.","journal-title":"J Virol"},{"issue":"2","key":"472_CR21","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1128\/JVI.01813-07","volume":"82","author":"S Alam","year":"2007","unstructured":"Alam S, Conway MJ, Chen HS. Meyers c. cigarette smoke carcinogen benzo[a]pyrene enhances human papillomavirus synthesis. J Virol. 2007;82(2):1053\u20138.","journal-title":"J Virol"},{"issue":"9312","key":"472_CR22","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S0140-6736(02)08151-5","volume":"359","author":"N Munoz","year":"2002","unstructured":"Munoz N, Franceschini S, Bosetti C, Moreno V, Herrero R, Smith JS, et al. Role of parity and human papillomavirus in cervical cancer: the iarc multicentric case-control study. Lancet. 2002;359(9312):1093\u2013101.","journal-title":"Lancet"},{"key":"472_CR23","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1002\/ijc.23762","volume":"123","author":"C Banura","year":"2008","unstructured":"Banura C, Franceschini S, va Doorn LJ, Arslan A, Kleter B, Wabwire-Mangen F, et al. Prevalence, incidence and clearence of human papillomavirus infection among young primiparous pregnant women in Kampala, Uganda. Int J Cancer. 2008;123:2180\u20137.","journal-title":"Int J Cancer"},{"issue":"12","key":"472_CR24","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.1002\/j.1460-2075.1987.tb02708.x","volume":"6","author":"B Gloss","year":"1987","unstructured":"Gloss B, Bernard HU, Seedorf K. Klock G. the upstream regulatory region of the human papillomavirus 16 contains an E2 protein-independent enhancer which is specifc for cervical carcinoma cells and regulated by glucocorticoid hormone. EMBO J. 1987;6(12):3735\u201343.","journal-title":"EMBO J"},{"issue":"9","key":"472_CR25","doi-asserted-by":"publisher","first-page":"6633","DOI":"10.1007\/s13277-015-3868-2","volume":"36","author":"SC Tan","year":"2015","unstructured":"Tan SC, Ankathil R. Genetic susceptibility to cervical cancer: role of common polymorphisms in apoptosis-related genes. Tumor Biol. 2015;36(9):6633\u201344.","journal-title":"Tumor Biol"},{"issue":"1","key":"472_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.tim.2010.10.002","volume":"19","author":"J Bodily","year":"2011","unstructured":"Bodily J, Laimins LA. Persistence of human papillomavirus infection\u00a0: keys to malignant progression. Trends Microbiol. 2011;19(1):33\u20139.","journal-title":"Trends Microbiol"},{"issue":"8","key":"472_CR27","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1097\/IGC.0b013e318265d334","volume":"22","author":"YT Tee","year":"2012","unstructured":"Tee YT, Yang SF, Wang PH, Tsai HT, Lin LY, Liao CL, et al. G801a polymorphism of human stromal cell-derived factor 1 gene raises no susceptibility to neoplastic lesions of uterine cervix. Int J Gynecol Cancer. 2012;22(8):1297\u2013302.","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"472_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0151851","volume":"11","author":"N Zanotta","year":"2016","unstructured":"Zanotta N, Tornesello ML, Annunziata C, Stellato G, Buonaguro FM, Comar M. Candidate soluble immune mediators in young women with high-risk human papillomavirus infection: high expression of chemokines promoting angiogenesis and cell proliferation. PLoS One. 2016;11(3):1\u201314.","journal-title":"PLoS One"},{"issue":"6","key":"472_CR29","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.biocel.2012.03.014","volume":"44","author":"G Timotijevi\u0107","year":"2012","unstructured":"Timotijevi\u0107 G, Mostarica MS, Miljkovi\u0107 D. CXCL12: role in neuroinflammation. Int J Biochem Cell Biol. 2012;44(6):838\u201341.","journal-title":"Int J Biochem Cell Biol"},{"key":"472_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1089\/vim.2013.0097","volume":"27","author":"HD Strickler","year":"2014","unstructured":"Strickler HD, Martinson J, Desai S, Xie X, Burk RD, Anastos K, et al. The relation of plasmacytoid dendritic cells (PDCS) and regulatory T-cells (Tregs) with HPV persistence in HIV-infected and HIV- uninfected women. Viral Immunol. 2014;27:20\u20135.","journal-title":"Viral Immunol"},{"key":"472_CR31","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.2353\/ajpath.2009.090295","volume":"175","author":"F Jaafar","year":"2009","unstructured":"Jaafar F, Righi E, Lindstorm V, Linton C, Nohadani M, Noorden SV, et al. Correlation of CXCL12 expression and FOXP3+ cell infiltration with human papillomavirus infection and clinicopathological progression of cervical cancer. Am J Pathol. 2009;175:1525\u201335.","journal-title":"Am J Pathol"},{"issue":"17","key":"472_CR32","doi-asserted-by":"publisher","first-page":"5056","DOI":"10.1158\/1078-0432.CCR-07-0859","volume":"13","author":"H Hirata","year":"2007","unstructured":"Hirata H, Hinoda Y, Kikuno N, Kawamoto K, Dahiya AV, Suehiro Y, et al. CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility. Clin Cancer Res. 2007;13(17):5056\u201362.","journal-title":"Clin Cancer Res"},{"key":"472_CR33","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1080\/15321819.2014.917428","volume":"36","author":"S Amara","year":"2015","unstructured":"Amara S, Chaar I, Khiari M, Ouinissi D, Hmida AB, Mzabi SR, et al. Relationship between SDF-1G801A polymorphism and its expression in Tunisian patients with colorectal cancer. J Immunoass Immunochem. 2015;36:182\u201394.","journal-title":"J Immunoass Immunochem"},{"issue":"1","key":"472_CR34","first-page":"11","volume":"19","author":"J Dimberg","year":"2007","unstructured":"Dimberg J, Hugander A, L\u00f6fgren S, Wags\u00e4ter D. Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients. Int J Mol Med. 2007;19(1):11\u20135.","journal-title":"Int J Mol Med"},{"key":"472_CR35","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.4049\/jimmunol.1500756","volume":"195","author":"J Schwerk","year":"2015","unstructured":"Schwerk J, Savan R. Translating the untranslated region. J Immunol. 2015;195:2963\u201371.","journal-title":"J Immunol"},{"issue":"12","key":"472_CR36","doi-asserted-by":"publisher","first-page":"e6041","DOI":"10.1371\/journal.pone.0004061","volume":"3","author":"Q Xiao","year":"2008","unstructured":"Xiao Q, Ye S, Oberhollenzer F, Mayr A, Jahangiri M, Willeit J, et al. SDF1 gene variation is associated with circulating SDF1\u03b1 level and endothelial progenitor cell number \u2013 the Burneck study. PLoS One. 2008;3(12):e6041.","journal-title":"PLoS One"},{"issue":"3","key":"472_CR37","first-page":"133","volume":"2","author":"SK Arya","year":"1999","unstructured":"Arya SK, Ginsberg CC, Davis-Warren A, D\u2019Costa J. In vitro genotype of SDF1 gene mutant that delays the onset of human immunodeficiency virus disease in vivo. J hum virol. 1999;2(3):133\u20138.","journal-title":"J hum virol"},{"issue":"7","key":"472_CR38","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1086\/343741","volume":"186","author":"A Soriano","year":"2002","unstructured":"Soriano A, Mart\u00ednez C, Garc\u00eda F, Plana M, Palou E, Lejeune M, et al. Plasma stromal cell \u2013 derived factor (SDF) \u2013 1 levels, SDF1 \u2013 3\u2019A genotype, and expression of CXCR4 on T lymphocytes: their impact on resistence to humam immunodeficiency virus tyoe 1 infection and its progression. J Infect Dis. 2002;186(7):922\u201331.","journal-title":"J Infect Dis"},{"issue":"3","key":"472_CR39","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/ncb2690","volume":"15","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Yang P, Sun T, Li D, Xu X, Rui Y, et al. miR-126 and miR126* repress recruitmentof mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis. Nat Cell Biol. 2013;15(3):284\u201394.","journal-title":"Nat Cell Biol"},{"issue":"3","key":"472_CR40","doi-asserted-by":"publisher","first-page":"e0121859","DOI":"10.1371\/journal.pone.0121859","volume":"10","author":"M Schulz","year":"2015","unstructured":"Schulz M, Karpova D, Spohn G, Damert A, Seifried E, Binder V, et al. Variant rs1801157 in the 3\u2019UTR of SDF-1\u03b2 does not explain variability of healthy-donor G-CSF responsiveness. PLoS One. 2015;10(3):e0121859.","journal-title":"PLoS One"},{"issue":"6","key":"472_CR41","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1182\/blood-2004-06-2289","volume":"105","author":"K Balabanian","year":"2005","unstructured":"Balabanian K, Lagane B, Pablos JL, Laurent L, Planchenault T, Verola O, et al. WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12. Blood. 2005;105(6):2449\u201358.","journal-title":"Blood"},{"issue":"12","key":"472_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1006039","volume":"12","author":"F Meuris","year":"2016","unstructured":"Meuris F, Carthagena L, Jaracz-Ros A, Gaudin F, Cutolo P, Deback C, et al. The CXCL12\/CXCR4 signaling pathway: a new susceptibility factor in human papillomavirus pathogenesis. PLoS Pathog. 2016;12(12):1\u201325.","journal-title":"PLoS Pathog"},{"issue":"1","key":"472_CR43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jmb.2005.02.016","volume":"348","author":"C Garc\u00eda-Moruja","year":"2005","unstructured":"Garc\u00eda-Moruja C, Alonso-Lobo JM, Rueda P, Torres C, Gonz\u00e1lez N, Bermejo M, et al. Functional characterization of SDF-1 proximal promoter. J Mol Biol. 2005;348(1):43\u201362.","journal-title":"J Mol Biol"},{"issue":"3","key":"472_CR44","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1089\/vim.2006.19.468","volume":"19","author":"O Peralta-Zaragoza","year":"2006","unstructured":"Peralta-Zaragoza O, Berm\u00fadez-Morales V, Guti\u00e9rrez-Xicotencatl L, Alcocer-Gonz\u00e1lez J, Recillas-Targa F, Madrid-Marina V. E6 and E7 oncoproteins from human papillomavirus type 16 induce activation of human transforming growth factor 1 promoter throughout SP1 recognition sequence. Viral Immunol. 2006;19(3):468\u201348.","journal-title":"Viral Immunol"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-018-0472-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12929-018-0472-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-018-0472-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T19:05:11Z","timestamp":1568747111000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/s12929-018-0472-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,18]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["472"],"URL":"https:\/\/doi.org\/10.1186\/s12929-018-0472-y","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,18]]},"assertion":[{"value":"11 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by Institutional Ethics Committee Involving Humans at State University of Londrina, Londrina \u2013 Paran\u00e1 (PR), Brazil (CEP\/UEL 133\/2012; CAAE 05505912.0.0000.5231). Study purpose and procedures were explained to all patients and written informed consent was obtained.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"69"}}